Holds one active US DMF and one valid CEP for gentamicin, filing since 1998. Its GMP is recognised in 13 markets.
Holds one active US DMF and one valid CEP for gentamicin, filing since 1998. Its GMP is recognised in 13 markets.
Holds 4 active US DMFs for gentamicin, filing since 2010. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 12 markets.
Holds one active US DMF for gentamicin, filing since 1996. Its 2024 FDA inspection closed as NAI.
Holds one active US DMF for gentamicin, filing since 2016. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for gentamicin. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 48 markets.
Registered with SFDA (Saudi Arabia) for gentamicin. Its GMP is recognised in 2 markets.
Registered with DAV (Vietnam) for gentamicin. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for gentamicin. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for gentamicin. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for gentamicin. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for gentamicin. Its GMP is recognised in 1 market.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Contract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for gentamicin and what filings they hold.
Chat with Fred, your AI analystFixed-dose combinations containing gentamicin. Each page leads with the verified API makers of every component.